320
Views
113
CrossRef citations to date
0
Altmetric
Review

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil

, , &
Pages 583-591 | Published online: 20 Mar 2015

References

  • Instituto Brasileiro de Geografia e EstatísticaNotícias: Em 2008, esperança de vida dos brasileiros chega a 72,86 anos. Comunicação Social, 01 de dezembro de 2009 Available from: http://saladeimprensa.ibge.gov.br/noticias?view=noticia&id=1&idnoticia=1507&busca=1&t=2008-esperanca-vida-brasileiros-chega-72-86-anosAccessed November 25, 2014
  • SchmidtMIDuncanBBAzevedo e SilvaGChronic non-communicable diseases in Brazil: burden and current challengesLancet20114377(9781)1949196121561658
  • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and TherapyOsteoporosis prevention, diagnosis and therapyJAMA2001285678579511176917
  • KanisJAAssessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study GroupOsteoporos Int199443683817696835
  • MarinhoBCGuerraLPDrummondJBSilvaBCSoaresMMThe burden of osteoporosis in BrazilArq Bras Endocrinol Metabol201458543444325166033
  • CamargoMBCendorogloMSRamosLRBone mineral density and osteoporosis among a predominantly Caucasian elderly population in the city of São Paulo, BrazilOsteoporos Int200516111451146015711778
  • MartiniLAMouraECSantosLCMaltaDCPinheiro MdeMPrevalence of self-reported diagnosis of osteoporosis in Brazil, 2006Rev Saude Publica200943210711619936505
  • PinheiroMMCiconelliRMJacques NdeOGenaroPSMartiniLAFerrazMBThe burden of osteoporosis in Brazil: regional data from fractures in adult men and women – the Brazilian Osteoporosis Study (BRAZOS)Rev Bras Reumatol201050211312721125148
  • PinheiroMMReis NetoETMachadoFSRisk factors for osteoporotic fractures and low bone density in pre and postmenopausal womenRev Saude Publica201044347948520549019
  • Buttros DdeANahas-NetoJNahasEACangussuLMBarralABKawakamiMSFatores de risco para osteoporose em mulheres na pós-menopausa do sudeste brasileiro [Risk factors for osteoporosis in postmenopausal women from southeast Brazilian]Rev Bras Ginecol Obstet2011336295302 Portuguese21877019
  • BaccaroLFde Souza Santos MachadoVCosta-PaivaLSousaMHOsisMJPinto-NetoAMFactors associated with osteoporosis in Brazilian women: a population-based household surveyArch Osteoporos201381–213823575503
  • WrightNCLookerACSaagKGThe recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spineJ Bone Miner Res201429112520252624771492
  • Institute of MedicineDietary Reference Intakes for Calcium and Vitamin DWashington, DCThe National Academies Press2011
  • PinheiroMMSchuchNJGenaroPSCiconelliRMFerrazMBMartiniLANutrient intakes related to osteoporotic fractures in men and women – the Brazilian Osteoporosis Study (BRAZOS)Nutr J2009298619178745
  • HausslerMRWhitfieldGKHausslerCAThe nuclear vitamin D receptor: biological and molecular regulatory properties revealedJ Bone Miner Res19981333253499525333
  • HolickMFChenTCLuZSauterEVitamin D and skin physiology: a D-lightful storyJ Bone Miner Res200722Suppl 2V28V3318290718
  • ArantesHPKulakCAFernandesCECorrelation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations TrialOsteoporos Int201324102707271223632825
  • National Osteoporosis FoundationClinician’s Guide to Prevention and Treatment of OsteoporosisWashington, DCNational Osteoporosis Foundation2014
  • KanisJAMeltonLJ3rdChristiansenCJohnstonCCKhaltaevNThe diagnosis of osteoporosisJ Bone Miner Res199498113711417976495
  • Ministério da SaúdeBrasilProtocolo Clínico e Diretrizes Terapêuticas: OsteoporosePortaria SAS/MS 451 de 09 de junho de 2014, retificada em 18 de junho de 2014 Available from: http://portalsaude.saude.gov.br/images/pdf/2014/dezembro/15/Osteoporose.pdfAccessed January 20, 2015
  • NelsonHDHaneyEMChouRDanaTFuRBougatsosCScreening for Osteoporosis: Systematic Review to Update the 2002 US Preventive Services Task Force Recommendation. Evidence Syntheses No 77AHRQ Publication No 10-05145-EF-1Rockville, MDAgency for Healthcare Research and Quality2010
  • The North American Menopause Society25th Annual Meeting of The North American Menopause Society October 15-October 18, 2014, Washington, DC. USPSTF Osteoporosis Screening Strategy: Confirming its predictive ability may prove challenging? (Abstract S-13)Menopause2014211213201369
  • PinheiroMMReis NetoETMachadoFSOmuraFSzejnfeldJSzejnfeldVLDevelopment and validation of a tool for identifying women with low bone mineral density and low-impact fractures: the São Paulo Osteoporosis Risk Index (SAPORI)Osteoporos Int20122313711379 Available from http://www2.unifesp.br/dmed/reumato/saporiAccessed November 25, 2014
  • Ministério da SaúdeBrasilPortaria 1101/GM em 12 de junho de 2002 Available from: http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2002/Gm/GM-1101.htmAccessed November 25, 2014
  • Instituto Brasileiro de Geografia e EstatísticaIndicadores sociodemográficos e de saúde no Brasil 2009Escassez e fartura: distribuição da oferta de equipamentos de diagnóstico por imagem no Brasil Available from: http://www.ibge.gov.br/home/estatistica/populacao/indic_sociosaude/2009/com_esca.pdfAccessed November 25, 2014
  • HernandesESLebrãoMLDuarteYASantosJLHealth insurance coverage of the elderly and socioepidemiological characteristics associatedRev Saude Publica20124661030103823503540
  • RossPDDavisJWEpsteinRSWasnichRDPre-existing fractures and bone mass predict vertebral fracture incidence in womenAnn Intern Med1991114119199232024857
  • Associação Médica Brasileira e Conselho Federal de MedicinaOsteoporose: DiagnósticoProjeto Diretrizes2011 Available from: http://ww.projetodiretrizes.org.br/diretrizes10/osteoporose_diagnostico.pdfAccessed January 20, 2015
  • GillespieLDRobertsonMCGillespieWJInterventions for preventing falls in older people living in the communityCochrane Database Syst Rev20092CD00714619370674
  • SheaBWellsGACranneyACalcium supplementation on bone loss in postmenopausal womenCochrane Database Syst Rev20041CD00452614974070
  • BollandMJAvenellABaronJAEffect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysisBMJ201029341c369120671013
  • WangLMansonJESessoHDCalcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trialsAm J Cardiovasc Drugs201212210511622283597
  • PaikJMCurhanGCSunQCalcium supplement intake and risk of cardiovascular disease in womenOsteoporos Int20142582047205624803331
  • MaedaSSBorbaVZCamargoMBRecommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis DArq Bras Endocrinol Metabol20145854113325166032
  • HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab20119671911193021646368
  • KanisJAJohnellOOdenAJohanssonHMcCloskeyEFRAX and the assessment of fracture probability in men and women from the UKOsteoporos Int20081938539718292978
  • EnsrudKELuiLYTaylorBCStudy of Osteoporotic Fractures Research GroupA comparison of prediction models for fractures in older women: is more better?Arch Intern Med2009169222087209420008691
  • BlackDMCummingsSRKarpfDBRandomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research GroupLancet19963489041153515418950879
  • CummingsSRBlackDMThompsonDEEffect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention TrialJAMA199828024207720829875874
  • ReginsterJMinneHWSorensenOHRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study GroupOsteoporos Int2000111839110663363
  • ChesnutCHIIISkagAChristiansenCEffects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisJ Bone Miner Res20041981241124915231010
  • HarrisSTBlumentalsWAMillerPDIbandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studiesCurr Med Res Opin200824123724518047776
  • HeijckmannACJuttmannJRWolffenbuttelBHIntravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosisNeth J Med200260831531912481878
  • BlackDMDelmasPDEastellROnce-yearly zoledronic acid for treatment of postmenopausal osteoporosisN Engl J Med2007356181809182217476007
  • RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
  • EttingerBBlackDMMitlakBHReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA1999282763764510517716
  • SirisEAdachiJDLuYEffects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene EvaluationOsteoporos Int2002131190791312415439
  • EnsrudKEStockJLBarrett-ConnorEEffects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart TrialJ Bone Miner Res200823111212017892376
  • KanisJAJohnellOBlackDMEffect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trialBone200333329330013678769
  • MartinoSCauleyJABarrett-ConnorEContinuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifeneJ Natl Cancer Inst200496231751176115572757
  • CummingsSREckertSKruegerKAThe effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationJAMA1999281232189219710376571
  • VogelVGCostantinoJPWickerhamDLEffects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialJAMA2006295232727274116754727
  • ChesnutCH3rdSilvermanSAndrianoKA randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study GroupAm J Med2000109426727610996576
  • NeerRMArnaudCDZanchettaJREffect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosisN Engl J Med2001344191434144111346808
  • CummingsSRSan MartinJMcClungMRDenosumab for prevention of fractures in postmenopausal women with osteoporosisN Engl J Med2009361875676519671655
  • MeunierPJRouxCSeemanEThe effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosisN Engl J Med2004350545946814749454
  • ReginsterJYSeemanEDe VernejoulMCStrontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) studyJ Clin Endocrinol Metab20059052816282215728210
  • BahiaLCostaAFernandesCLuizRRCavalcantiMdLTSegmentation of the demand of the plans and private insurances of health: an analysis of the information of PNAD/98Ciênc Saúde Coletiva200274671686
  • BrandãoCMFerréFMachadoGPPublic spending on drugs for the treatment of osteoporosis in post-menopauseRev Saude Publica201347239040224037367
  • MoraesLFSilvaENSilvaDAPaulaAPExpenditures on the treatment of osteoporosis in the elderly in Brazil (2008–2010): analysis of associated factorsRev Bras Epidemiol201417371973425272264
  • de Castro GomesDAValadaresALPinto-NetoAMMoraisSSCosta-PaivaLAbility to follow drug treatment with calcium and vitamin D in postmenopausal women with reduced bone massMenopause201219998999422668820
  • GomesDCCosta-PaivaLFarhatFCPedroAOPinto-NetoAMAbility to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone massMenopause201118553153621242816
  • AbrahamsenBAdverse effects of bisphosphonatesCalcif Tissue Int201086642143520407762
  • WattsNBDiabDLLong-term use of bisphosphonates in osteoporosisJ Clin Endocrinol Metab20109541555156520173017